Georg Widhalm

9.8k total citations · 1 hit paper
213 papers, 5.7k citations indexed

About

Georg Widhalm is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Georg Widhalm has authored 213 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Genetics, 93 papers in Pulmonary and Respiratory Medicine and 63 papers in Oncology. Recurrent topics in Georg Widhalm's work include Glioma Diagnosis and Treatment (123 papers), Brain Metastases and Treatment (69 papers) and Meningioma and schwannoma management (30 papers). Georg Widhalm is often cited by papers focused on Glioma Diagnosis and Treatment (123 papers), Brain Metastases and Treatment (69 papers) and Meningioma and schwannoma management (30 papers). Georg Widhalm collaborates with scholars based in Austria, Germany and United States. Georg Widhalm's co-authors include Matthias Preusser, Anna S. Berghoff, Karin Dieckmann, Barbara Kiesel, Johannes A. Hainfellner, Engelbert Knosp, Christine Marosi, Adelheid Wöhrer, Peter Birner and Stefan Wolfsberger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Georg Widhalm

200 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

2014 445 citations Anna S. Berghoff, Barbara Kiesel et al. profile →

Peers

Countries citing papers authored by Georg Widhalm

Since Specialization

Citations

This map shows the geographic impact of Georg Widhalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Widhalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Widhalm more than expected).

Fields of papers citing papers by Georg Widhalm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Widhalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Widhalm. The network helps show where Georg Widhalm may publish in the future.

Co-authorship network of co-authors of Georg Widhalm

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Widhalm. A scholar is included among the top collaborators of Georg Widhalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Widhalm. Georg Widhalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of the Porphyrin Peak Shift and Fluorescence Lifetime in Gliomas with Different Tumor Grades, Intratumoral Regions, and Visible Fluorescence Status 2024 ·Diagnostics ·(unknown), David Reichert, Marco Andreana, Angelika Unterhuber, (unknown), (unknown), Barbara Kiesel, Mario Mischkulnig, Thomas Roetzer-Pejrimovsky, Adelheid Wöehrer, Mitchel S. Berger, Rainer A. Leitgeb, Georg Widhalm	0
2	Detection of a Water-Soluble Hypericin Formulation in Glioblastoma Tissue with Fluorescence Lifetime and Intensity Using a Dual-Tap CMOS Camera System 2024 ·Diagnostics ·Mario Mischkulnig, David Reichert, Lionel Wightman, (unknown), (unknown), (unknown), Barbara Kiesel, (unknown), (unknown), (unknown), Angelika Unterhuber, Marco Andreana, Beate Rinner, Andreas Kubin, Rainer A. Leitgeb, Georg Widhalm	1
3	5-ALA localises to the autophagy compartment and increases its fluorescence upon autophagy enhancement through caloric restriction and spermidine treatment in human glioblastoma 2024 ·Biochemistry and Biophysics Reports ·(unknown), Jurgen Kriel, Lize Engelbrecht, (unknown), Georg Widhalm, (unknown), (unknown), Ben Loos	0
4	537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases 2023 ·Annals of Oncology ·Ariane Steindl, Arne Kienzle, Erwin Tomasich, J.M. Berger, (unknown), (unknown), M. Korpan, (unknown), Angelika M. Starzer, Barbara Kiesel, Georg Widhalm, Franziska Eckert, Matthias Preusser, Anna S. Berghoff	1
5	Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation—A Comparative Study 2023 ·Cancers ·Wolfgang Marik, Pedro Lima Cardoso, Elisabeth Springer, Wolfgang Bogner, Matthias Preusser, Georg Widhalm, Gilbert Hangel, Johannes A. Hainfellner, Ivo Rausch, Michael Weber, Victor Schmidbauer, Tatjana Traub‐Weidinger, Siegfried Trattnig	3
6	Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer 2023 ·Clinical Cancer Research ·Erwin Tomasich, Ariane Steindl, (unknown), (unknown), (unknown), (unknown), Rainer Puhr, Johannes A. Hainfellner, Leonhard Müllauer, Georg Widhalm, Franziska Eckert, Rupert Bartsch, Gerwin Heller, Matthias Preusser, Anna S. Berghoff	14
7	Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment 2023 ·PLoS ONE ·Mario Mischkulnig, (unknown), Lisa I. Wadiura, (unknown), Barbara Kiesel, Karl Rössler, Georg Widhalm, Christian Dorfer	3
8	Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns 2022 ·Clinical Cancer Research ·Maximilian J. Mair, (unknown), Gerwin Heller, Rainer Puhr, Erwin Tomasich, (unknown), (unknown), Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Martin Aichholzer, Serge Weis, Tim J. von Oertzen, Julia Furtner, Josef Pichler, Matthias Preusser, Anna S. Berghoff	8
9	Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization 2022 ·Photodiagnosis and Photodynamic Therapy ·Mario Mischkulnig, (unknown), Friedrich Erhart, Barbara Kiesel, (unknown), Arthur Hosmann, (unknown), (unknown), Denise Traxler, Martin Borkovec, Karl Rössler, Georg Widhalm, Lisa I. Wadiura	3
10	MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy 2022 ·Cancers ·(unknown), Malik Galijašević, Stephanie Mangesius, Hans H. Goebel, Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Günther Stockhammer, Sarah Iglseder, Christian F. Freyschlag, Stefan Oberndorfer, (unknown), Gord von Campe, Thomas Czech, (unknown), Tadeja Urbanic Purkart, Christine Marosi, Thomas Felzmann, Martha Nowosielski	7
11	Improved Protoporphyrin IX-Guided Neurosurgical Tumor Detection with Frequency-Domain Fluorescence Lifetime Imaging 2022 ·Applied Sciences ·David Reichert, (unknown), Johanna Gesperger, Lisa I. Wadiura, (unknown), Thomas Roetzer-Pejrimovsky, Adelheid Wöehrer, (unknown), (unknown), Wolfgang Drexler, Barbara Kiesel, Georg Widhalm, Rainer A. Leitgeb, Angelika Unterhuber, Marco Andreana	3
12	5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers 2021 ·Cancers ·Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, (unknown), Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer-Pejrimovsky, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn L. Hervey‐Jumper, Mitchel S. Berger, Georg Widhalm	28
13	Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years 2021 ·Cancers ·Barbara Kiesel, Lisa I. Wadiura, Mario Mischkulnig, (unknown), (unknown), Martin Borkovec, Julia Freund, (unknown), Matthias Millesi, Anna S. Berghoff, Julia Furtner, Adelheid Wöehrer, Georg Widhalm	7
14	Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” 2021 ·Cancers ·Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, (unknown), Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer-Pejrimovsky, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn L. Hervey‐Jumper, Mitchel S. Berger, Georg Widhalm	4
15	Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas 2021 ·Cancers ·Mario Mischkulnig, Barbara Kiesel, Daniela Lötsch, Thomas Roetzer-Pejrimovsky, Martin Borkovec, Lisa I. Wadiura, Karl Roessler, Shawn L. Hervey‐Jumper, Josef Penninger, Mitchel S. Berger, Georg Widhalm, Friedrich Erhart	5
16	Domain Mapping and Deep Learning from Multiple MRI Clinical Datasets for Prediction of Molecular Subtypes in Low Grade Gliomas 2020 ·Brain Sciences ·(unknown), Irene Yu‐Hua Gu, Mitchel S. Berger, Johan Pallud, Derek G. Southwell, Georg Widhalm, Alexandre Roux, (unknown), Asgeir Store Jakola	28
17	Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer 2020 ·European Journal of Cancer ·Anna S. Berghoff, (unknown), Angelika M. Starzer, Nicolás Ballarini, Fabian Wolpert, Elisabeth Bergen, Peter Wolf, Ariane Steindl, Georg Widhalm, Brigitte Gatterbauer, Christine Marosi, Karin Dieckmann, Rupert Bartsch, Thomas Scherer, Franz Koenig, Michael Krebs, Michael Weller, Matthias Preusser	12
18	5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients 2018 ·Neurosurgical FOCUS ·Barbara Kiesel, Matthias Millesi, Adelheid Wöehrer, Julia Furtner, (unknown), Thomas Roetzer-Pejrimovsky, Mario Mischkulnig, Stefan Wolfsberger, Matthias Preusser, Engelbert Knosp, Georg Widhalm	44
19	Analysis of 5-aminolevulinic acid–induced fluorescence in 55 different spinal tumors 2014 ·Neurosurgical FOCUS ·Matthias Millesi, Barbara Kiesel, Adelheid Wöehrer, Johannes A. Hainfellner, Klaus Novak, Mauricio Martínez-Moreno, Stefan Wolfsberger, Engelbert Knosp, Georg Widhalm	51
20	Application of the ISYS1 robotic device for stereotactic neurosurgical interventions: a preclinical phantom trial. 2013 ·Georgi Minchev, Gernot Kronreif, Luther H. Holton, Georg Widhalm, (unknown), Barbara Kiesel, Mauricio Martínez-Moreno, Alexander Micko, Engelbert Knosp, Michael Vogele, Stefan Wolfsberger	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact